Hunting Hill Global Capital LLC Invests $559,000 in Astera Labs, Inc. $ALAB

Hunting Hill Global Capital LLC bought a new position in Astera Labs, Inc. (NASDAQ:ALABFree Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 3,362 shares of the company’s stock, valued at approximately $559,000.

Other institutional investors have also recently made changes to their positions in the company. Assetmark Inc. grew its stake in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after acquiring an additional 101 shares in the last quarter. Smartleaf Asset Management LLC grew its stake in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after acquiring an additional 152 shares in the last quarter. Hilltop National Bank grew its stake in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after acquiring an additional 100 shares in the last quarter. Aventura Private Wealth LLC bought a new stake in shares of Astera Labs in the 4th quarter worth $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in shares of Astera Labs in the 4th quarter worth $33,000. Institutional investors own 60.47% of the company’s stock.

Insider Transactions at Astera Labs

In other news, General Counsel Philip Mazzara sold 796 shares of the stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $291.03, for a total value of $231,659.88. Following the sale, the general counsel directly owned 103,343 shares of the company’s stock, valued at approximately $30,075,913.29. This represents a 0.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Jack R. Lazar sold 10,000 shares of the stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the completion of the sale, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. The trade was a 11.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 2,161,256 shares of company stock valued at $459,844,296. Company insiders own 10.40% of the company’s stock.

Analyst Ratings Changes

ALAB has been the topic of a number of research analyst reports. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 26th. Loop Capital initiated coverage on shares of Astera Labs in a report on Thursday, March 5th. They issued a “buy” rating and a $250.00 price target on the stock. Morgan Stanley boosted their price target on shares of Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a report on Wednesday, May 6th. Royal Bank Of Canada boosted their price target on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $233.75.

View Our Latest Stock Report on Astera Labs

Astera Labs Stock Up 3.6%

NASDAQ ALAB opened at $374.68 on Thursday. The company has a market cap of $64.22 billion, a PE ratio of 253.16, a price-to-earnings-growth ratio of 4.79 and a beta of 3.95. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $398.13. The firm’s 50-day simple moving average is $252.64 and its two-hundred day simple moving average is $183.89.

Astera Labs (NASDAQ:ALABGet Free Report) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period in the prior year, the firm earned $0.33 earnings per share. The company’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. As a group, equities research analysts anticipate that Astera Labs, Inc. will post 1.84 EPS for the current year.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

Astera Labs Company Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

See Also

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALABFree Report).

Institutional Ownership by Quarter for Astera Labs (NASDAQ:ALAB)

Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.